These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16033704)

  • 1. Description (reporting the actual words used in written letters) of the neuropsychological and psychopathological modifications produced by dopaminergic treatment in a young patient with Parkinson's disease.
    Cannas A; Solla P; Floris G; Tacconi P; Fulgheri P; Congia S; Spissu A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):138-40. PubMed ID: 16033704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia.
    Cannas A; Solla P; Floris G; Tacconi P; Loi D; Marcia E; Marrosu MG
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1539-41. PubMed ID: 16904253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater motor improvement in right hemibody Parkinson's patients after dopaminergic medications.
    Foster PS; Drago V; Skidmore F; Skoblar BM; Crucian GP; Heilman KM
    Parkinsonism Relat Disord; 2009 Jan; 15(1):20-3. PubMed ID: 18387842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study.
    Euteneuer F; Schaefer F; Stuermer R; Boucsein W; Timmermann L; Barbe MT; Ebersbach G; Otto J; Kessler J; Kalbe E
    Neuropsychologia; 2009 Nov; 47(13):2882-90. PubMed ID: 19545579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease.
    Riederer P; Gerlach M; Müller T; Reichmann H
    Parkinsonism Relat Disord; 2007 Dec; 13(8):466-79. PubMed ID: 17919963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary function and the somatotrophic system in patients with idiopathic Parkinson's disease under chronic dopaminergic therapy.
    Schaefer S; Vogt T; Nowak T; Kann PH;
    J Neuroendocrinol; 2008 Jan; 20(1):104-9. PubMed ID: 18081558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in Parkinson's disease: one year follow-up of a randomised observer-blind multi centre trial.
    Esselink RA; de Bie RM; de Haan RJ; Steur EN; Beute GN; Portman AT; Schuurman PR; Bosch DA; Speelman JD
    Acta Neurochir (Wien); 2006 Dec; 148(12):1247-55; discussion 1255. PubMed ID: 17072792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.
    Ardouin C; Voon V; Worbe Y; Abouazar N; Czernecki V; Hosseini H; Pelissolo A; Moro E; Lhommée E; Lang AE; Agid Y; Benabid AL; Pollak P; Mallet L; Krack P
    Mov Disord; 2006 Nov; 21(11):1941-6. PubMed ID: 16972268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levodopa and cognitive disorders in Parkinson's disease].
    Leiva-Santana C; Alvarez-Saúco M
    Rev Neurol; 2006 Jul 16-31; 43(2):95-100. PubMed ID: 16838257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine may reverse punding in Parkinson's disease--observation in a patient.
    Kashihara K; Imamura T
    Mov Disord; 2008 Jan; 23(1):129-30. PubMed ID: 17960816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli.
    Bowers D; Miller K; Mikos A; Kirsch-Darrow L; Springer U; Fernandez H; Foote K; Okun M
    Brain; 2006 Dec; 129(Pt 12):3356-65. PubMed ID: 17095520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation.
    Duvoisin RC
    Neurology; 1989 Nov; 39(11 Suppl 2):4-6. PubMed ID: 2573862
    [No Abstract]   [Full Text] [Related]  

  • 17. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.
    Gómez-Esteban JC; Zarranz JJ; Lezcano E; Velasco F; Ciordia R; Rouco I; Losada J; Bilbao I
    Mov Disord; 2006 Jul; 21(7):983-8. PubMed ID: 16602112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Onset of dopaminergic therapy in Parkinson's disease: six good reasons not to delay it].
    Linazasoro G
    Neurologia; 2008 Jun; 23(5):299-305. PubMed ID: 18247187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug therapy for Parkinson's disease.
    Hermanowicz N
    Semin Neurol; 2007 Apr; 27(2):97-105. PubMed ID: 17390254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological gambling secondary to dopaminergic therapy in Parkinson's disease.
    Drapier D; Drapier S; Sauleau P; Derkinderen P; Damier P; Allain H; Vérin M; Millet B
    Psychiatry Res; 2006 Nov; 144(2-3):241-4. PubMed ID: 17011634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.